GSK and generic drugmakers prepare for marathon CMA court fight
GlaxoSmithKline sold paroxetine as Seroxat (Credit: Flickr user Jussi Mononen (CC-BY-2.0))
Six companies are set to begin a marathon five-week appeal against the UK Competition and Markets Authority’s first pay-for-delay decision.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now